Xuanyong Lu

938 total citations
26 papers, 781 citations indexed

About

Xuanyong Lu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xuanyong Lu has authored 26 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Xuanyong Lu's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). Xuanyong Lu is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). Xuanyong Lu collaborates with scholars based in United States, United Kingdom and Germany. Xuanyong Lu's co-authors include Timothy M. Block, Anand S. Mehta, Raymond A. Dwek, Baruch S. Blumberg, Jason Lamontagne, Wolfram H. Gerlich, Terry D. Butters, Bud C. Tennant, David M. Lansky and Brent Korba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Xuanyong Lu

26 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuanyong Lu United States 16 473 319 246 145 103 26 781
Muriel Lavie France 16 285 0.6× 307 1.0× 202 0.8× 92 0.6× 30 0.3× 23 769
M. A. Brothers United States 9 332 0.7× 252 0.8× 327 1.3× 259 1.8× 62 0.6× 12 1.0k
Mohsan Saeed United States 19 402 0.8× 434 1.4× 322 1.3× 451 3.1× 27 0.3× 44 1.1k
Catalin Lazar Romania 16 390 0.8× 232 0.7× 270 1.1× 131 0.9× 16 0.2× 27 748
Olaf Weber Germany 18 733 1.5× 412 1.3× 191 0.8× 240 1.7× 108 1.0× 34 1.3k
Tsuyoshi Adachi Japan 12 406 0.9× 694 2.2× 370 1.5× 305 2.1× 177 1.7× 20 1.2k
Mark L. Collins United States 12 237 0.5× 179 0.6× 420 1.7× 181 1.2× 18 0.2× 16 853
Kevin Steffy United States 15 407 0.9× 153 0.5× 193 0.8× 105 0.7× 79 0.8× 23 747
Mami Matsuda Japan 20 401 0.8× 385 1.2× 363 1.5× 230 1.6× 8 0.1× 42 1.1k
Julie Q. Hang United States 16 228 0.5× 238 0.7× 257 1.0× 340 2.3× 118 1.1× 20 718

Countries citing papers authored by Xuanyong Lu

Since Specialization
Citations

This map shows the geographic impact of Xuanyong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanyong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanyong Lu more than expected).

Fields of papers citing papers by Xuanyong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuanyong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanyong Lu. The network helps show where Xuanyong Lu may publish in the future.

Co-authorship network of co-authors of Xuanyong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuanyong Lu. A scholar is included among the top collaborators of Xuanyong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuanyong Lu. Xuanyong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Xuanyong. (2011). Pathogenesis of Hepatitis B Virus (HBV)-Mediated Liver Injury. North American Journal of Medicine and Science. 4(1). 1–1. 5 indexed citations
3.
Lamontagne, Jason, et al.. (2011). Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis. Immunology. 134(4). 398–408. 19 indexed citations
4.
Guo, Haitao, Xiao‐Ben Pan, Richeng Mao, et al.. (2010). Alkylated Porphyrins Have Broad Antiviral Activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses. Antimicrobial Agents and Chemotherapy. 55(2). 478–486. 49 indexed citations
5.
Lamontagne, Jason, Mark H. Pinkerton, Timothy M. Block, & Xuanyong Lu. (2009). Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis. Journal of Virology. 84(2). 907–917. 32 indexed citations
6.
Lu, Xuanyong, et al.. (2008). Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis. APOPTOSIS. 13(4). 483–494. 23 indexed citations
7.
Lu, Xuanyong & Ke‐Qin Hu. (2005). Advances in Hepatitis B Research: From Virology to Clinical Management (A Special Issue). International Journal of Medical Sciences. 2(1). 1–1. 4 indexed citations
8.
Lu, Cheng‐Chan, Jui‐Chen Tsai, Wei‐Jen Yao, et al.. (2005). Novel Autoregulatory Function of Hepatitis B Virus M Protein on Surface Gene Expression. Journal of Biological Chemistry. 280(30). 27742–27754. 10 indexed citations
9.
Lu, Xuanyong, et al.. (2005). High level expression of apoptosis inhibitor in hepatoma cell line expressing Hepatitis B virus. International Journal of Medical Sciences. 2(1). 30–35. 24 indexed citations
10.
Lu, Xuanyong & Timothy M. Block. (2004). Study of the early steps of the Hepatitis B Virus life cycle. International Journal of Medical Sciences. 1(1). 21–33. 25 indexed citations
11.
Lu, Xuanyong, et al.. (2004). A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg. Journal of Virological Methods. 119(1). 51–54. 5 indexed citations
12.
Norton, Pamela A., Qiaoke Gong, Anand S. Mehta, Xuanyong Lu, & Timothy M. Block. (2003). Hepatitis B Virus-Mediated Changes of Apolipoprotein mRNA Abundance in Cultured Hepatoma Cells. Journal of Virology. 77(9). 5503–5506. 28 indexed citations
13.
Lu, Xuanyong, et al.. (2001). Hepatitis B Virus MHBs Antigen Is Selectively Sensitive to Glucosidase-Mediated Processing in the Endoplasmic Reticulum. DNA and Cell Biology. 20(10). 647–656. 13 indexed citations
14.
Lu, Xuanyong, et al.. (2001). Limited proteolysis induces woodchuck hepatitis virus infectivity for human HepG2 cells. Virus Research. 73(1). 27–40. 15 indexed citations
15.
Mehta, Anand S., Xuanyong Lu, Timothy M. Block, et al.. (2001). Synovial stimulatory protein fragments copurify with woodchuck hepatitis virus: Implications for the etiology of arthritis in chronic hepatitis B virus infection. Arthritis & Rheumatism. 44(2). 486–487. 11 indexed citations
16.
Block, Timothy M., Xuanyong Lu, Anand S. Mehta, et al.. (1998). Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nature Medicine. 4(5). 610–614. 125 indexed citations
17.
Lu, Xuanyong, et al.. (1997). Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proceedings of the National Academy of Sciences. 94(6). 2380–2385. 46 indexed citations
18.
Mehta, Anand S., Xuanyong Lu, Timothy M. Block, Baruch S. Blumberg, & Raymond A. Dwek. (1997). Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proceedings of the National Academy of Sciences. 94(5). 1822–1827. 115 indexed citations
19.
Lu, Xuanyong, Anand S. Mehta, Raymond A. Dwek, Terry D. Butters, & Timothy M. Block. (1995). Evidence That N-Linked Glycosylation Is Necessary for Hepatitis B Virus Secretion. Virology. 213(2). 660–665. 78 indexed citations
20.
Gerlich, Wolfram H., K.‐H. Heermann, & Xuanyong Lu. (1992). Functions of hepatitis B surface proteins. PubMed. 4. 129–132. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muriel Lavie Breakdown of academic impact, for papers by M. A. Brothers Breakdown of academic impact, for papers by Mohsan Saeed Breakdown of academic impact, for papers by Catalin Lazar Breakdown of academic impact, for papers by Olaf Weber Breakdown of academic impact, for papers by Tsuyoshi Adachi Breakdown of academic impact, for papers by Mark L. Collins Breakdown of academic impact, for papers by Kevin Steffy Breakdown of academic impact, for papers by Mami Matsuda Breakdown of academic impact, for papers by Julie Q. Hang
Rankless by CCL
2026